Invite your friends and start networking.
Select your friends below to invite them to join!
Thank you for joining Pharma IQ
As you have selected Cold Chain as your primary interest area, you will gain the benefit of an additional membership to our dedicated website, Cold Chain IQ, the in-depth resource center on all things temperature control logistics and QA for life sciences. Learn more at www.coldchainiq.com
Get Started on Pharma IQ!
Join a Group
Start creating groups on and network with other professionals by creating communities around issues that are important to you. You'll also be able to join event-related groups to extend the networking and learning experience online. Get Started!
Complete your profile
Your Profile will allow you to monitor the latest activity. Keep updated on the latest group activity, see contact status, and easily find the answers to your questions. Get Started!
View Content
By inviting your colleagues today, they will gain access to the growing library of multimedia content and networking tools available.
Contributor:
Ryta Kuzel
Posted:
04/29/2013 12:00:00 AM EDT
The European Commission implemented new laws regarding packaging for drugs that have a potential safety risk requiring them to be marked with an inverted black triangle. Ryta Kuzel, Director and Owner of VigiReg Consulting Ltd, which specialises in Pharmacovigilance auditing and Regulatory Affairs, explains the impact of these new regulations and gives a summary of the regulatory framework requirements for pharmaceuticals in Europe.
Read more
Contributor:
Massimo De Carlo
Posted:
04/17/2013 12:00:00 AM EDT
A close up look at F. Hoffmann le Roche global artwork change management process & system - from artwork errors and business needs to their new system and process requirements.
Read more
Contributor:
Johannes Schoen
Posted:
03/05/2013 12:00:00 AM EST
Johannes Schoen from Boehringer Ingelheim shares best practices for preparing for the Falsified Medicines Directive (FMD) and his predictions for the next 5 years regarding the FMD and serialisation.
Read more
Contributor:
Amber Scorah
Posted:
08/10/2012 12:00:00 AM EDT
To understand where we are going, we need to understand where we’ve been. In this interview, Paul Beninger, Vice President, Global Patient Safety and Risk Management at Genzyme, joins Pharma IQ to take a look at where the pharmaceutical industry is now, where we have been, and what the future looks like in pharmacovigilance.
Read more
Contributor:
Amber Scorah
Posted:
08/10/2012 12:00:00 AM EDT
United Therapeutics has undertaken a fully outsourced model for case processing. Maintaining the efficiencies the model was expected to provide requires establishing a functional integration of the vendor into the global pharmacovigilance system, and effective management of the relationship. In this interview Dr. Anthony Lassiter, Head of Global Drug Safety at United Therapeutics, joins Pharma IQ to give an overview and analysis of their model.
Read more
Contributor:
Roger Bate
Posted:
07/06/2012 12:00:00 AM EDT
"If you think about it, you may not know the exact cow your pint of milk comes from, but you often know certainly from which country that milk has come from. At the moment, we simply can’t say this drug was made with these ingredients from these countries, and I think that has to change," said Roger Bate, American Enterprise Institute.
Read more
Contributor:
Bryan Camoens
Posted:
05/09/2012 12:00:00 AM EDT
"Compliance with EPPV regulation is not the big issue. The bigger issue is that we need to validate whether EPPV is actually working in terms of pharmacovigilance activity leading to minimizing the risk of patients. In near future, we need to assess the effectiveness of EPPV," said Dr. Shinichi Nishiuma, Senior Medical Advisor & Lead physician of Global Patient Safety in Japan for Lilly Research Laboratories Japan.
Read more
Contributor:
Adrian Spillman
Posted:
05/01/2012 12:00:00 AM EDT
Adrian Spillman, Global Head of Intellectual Property at Intercell, joins Legal IQ to discuss how to decide when to patent and how to tackle patenting in unknown markets.
Read more
In Part 2 of this roundtable session, our industry experts discuss specifications around quality agreements, what to consider when conducting due diligence and tips on achieving project manager success when outsourcing operations.
Read more
Contributor:
Tassilo Korab
Posted:
03/28/2012 12:00:00 AM EDT
Up to 50% of patients may not be taking their medication as prescribed. Tassilo Korab, Executive Director for the European Healthcare Packaging Compliance Council, explains how the Pharmaceutical Industry can optimise packaging to increase chronic patient compliance.
Read more
Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluations Department, Saudi FDA, joins Pharma IQ to discuss the Saudi FDA’s pharmacovigilance system and what new guidelines he predicts will be areas for discussion amongst pharma/biodiversity companies.
Read more
Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!